| Literature DB >> 26974335 |
Marwan Osman1,2,3, Dima El Safadi4,2,3, Amandine Cian4, Sadia Benamrouz4,5, Céline Nourrisson6,7, Philippe Poirier6,7, Bruno Pereira8, Romy Razakandrainibe9, Anthony Pinon10, Céline Lambert8, Ivan Wawrzyniak6, Fouad Dabboussi2,3, Frederic Delbac6, Loïc Favennec9, Monzer Hamze2,3, Eric Viscogliosi4, Gabriela Certad4,11.
Abstract
BACKGROUND: Intestinal protozoan infections are confirmed as major causes of diarrhea, particularly in children, and represent a significant, but often neglected, threat to public health. No recent data were available in Lebanon concerning the molecular epidemiology of protozoan infections in children, a vulnerable population at high risk of infection. METHODOLOGY AND PRINCIPALEntities:
Mesh:
Year: 2016 PMID: 26974335 PMCID: PMC4790957 DOI: 10.1371/journal.pntd.0004496
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1Map of Tripoli, showing the location of Al Zahra’ and Jil Alwa’ed schools.
Demographic characteristics of the study population.
| Non-infected children (N = 37) | Infected children (N = 212) | |
|---|---|---|
| Age (median) | 8.48 ± 0.50 | 9.5 ± 0.21 |
| Gender | ||
| Male | 20 | 129 |
| Female | 17 | 83 |
| Children in the LSES group | 19 | 138 |
| Children in the HSES group | 18 | 74 |
LSES: low socioeconomic status, HSES: high socioeconomic status
Fig 2Distribution of single and mixed parasitic infections in schoolchildren in Tripoli.
Single, double, triple and quadruple infections are shown. Prevalences of Blastocystis spp., D. fragilis, Cryptosporidium spp. and G. duodenalis are based on molecular diagnosis.
Distribution of protozoan infections among schoolchildren in Tripoli according to risk factors.
| Risk factor | Prevalence | Prevalence | Prevalence | Prevalence | |||||
|---|---|---|---|---|---|---|---|---|---|
| 61.5% (8/13) | 1.0; 0.93 [0.3–2.9] | 53.8% (7/13) | 0.77; 0.74 [0.2–2.3] | 23.1% (3/13) | 0.76; 0.74 [0.2–2.8] | 38.4% (5/13) | |||
| 63.1% (149/236) | 61% (144/236) | 28.8% (68/236) | 8.9% (21/236) | ||||||
| 66.4% (99/149) | 0.18; 1.4 [0.9–2.4] | 63.1% (94/149) | 0.34; 1.3 [0.8–2.2] | 31.5% (47/149) | 0.20; 1.5 [0.8–2.6] | 10.7% (16/149) | 0.85; 1.1 [0.5–2.5] | ||
| 58% (58/100) | 57% (57/100) | 24% (24/100) | 10% (10/100) | ||||||
| 66.2% (104/157) | 0.18; 1.4 [0.8–2.4] | 63.7% (100/157) | 0.23; 1.4 [0.8–2.4] | 36.3% (57/157) | 10.8% (17/157) | 0.83; 1.1 [0.5–2.6] | |||
| 57.6% (53/92) | 55.4% (51/92) | 15.2% (14/92) | 9.8% (9/92) | ||||||
| 36.8% (7/19) | 57.9% (11/19) | 0.80; 0.9 [0.3–2.3] | 15.8% (3/19) | 0.20; 0.4 [0.1–1.6] | 15.8% (3/19) | 0.43; 1.7 [0.5–6.2] | |||
| 65.2% (150/230) | 60.9% (140/230) | 29.6% (68/230) | 10% (23/230) | ||||||
| 64.6% (126/195) | 0.33; 1.4 [0.7–2.5] | 62.1% (121/195) | 0.39; 1.3 [0.7–2.4] | 32.3% (63/195) | 9.7% (19/195) | 0.49; 0.7 [0.3–1.8] | |||
| 57.4% (31/54) | 55.6% (30/54) | 14.8% (8/54) | 13% (7/54) | ||||||
| 58.3% (35/60) | 0.38; 0.8 [0.4–1.4] | 56.7% (34/60) | 0.47; 0.8 [0.4–1.5] | 13.3% (8/60) | 13.3% (8/60) | 0.40; 1.5 [0.6–3.6] | |||
| 64.6% (122/189) | 61.9% (117/189) | 33.3% (63/189) | 9.5% (18/189) | ||||||
| 72.8% (56/77) | 72.8% (56/77) | 51.9% (40/77) | 14.3% (11/77) | 0.18; 1.7 [0.8–4.0] | |||||
| 58.7% (101/172) | 55.2% (95/172) | 18% (31/172) | 8.7% (15/172) | ||||||
| 68.8% (86/125) | 0.06; 1.6 [0.9–2.7] | 64% (80/125) | 0.27; 1.3 [0.8–2.2] | 42.4% (53/125) | 15.2% (19/125) | ||||
| 57.3% (71/124) | 57.3% (71/124) | 14.5% (18/124) | 5.6% (7/124) | ||||||
| 71.1% (81/114) | 65.8% (75/114) | 0.13; 1.5 [0.9–2.5] | 44.7% (51/114) | 13.2% (15/114) | 0.20; 1.7 [0.8–3.9] | ||||
| 56.3% (76/135) | 56.3% (76/135) | 14.8% (20/135) | 8.1% (11/135) | ||||||
| 71.4% (45/63) | 0.11; 1.7 [0.9–3.1] | 60.3% (38/63) | 0.95; 1.0 [0.5–1.8] | 42.9% (27/63) | 22.2% (14/63) | ||||
| 60.2% (112/186) | 60.8% (113/186) | 23.7% (44/186) | 6.5% (12/186) | ||||||
| 46.2% (6/13) | 0.24; 0.5 [0.2–1.5] | 53.8% (7/13) | 0.61; 0.7 [0.2–2.3] | 46.2% (6/13) | 0.2; 2.3 [0.7–7.0] | 38.5% (5/13) | |||
| 64% (151/236) | 61% (144/236) | 27.5% (65/236) | 8.9% (21/236) | ||||||
| 63% (17/27) | 0.99; 1.0 [0.4–2.3] | 59.3% (16/27) | 0.88; 0.9 [0.4–2.1] | 37% (10/27) | 0.37; 1.6 [0.7–3.6] | 14.8% (4/27) | 0.50; 1.6 [0.5–5.0] | ||
| No | 63.1% (140/222) | 60.8% (135/222) | 27.5% (61/222) | 9.9% (22/222) | |||||
*: Diagnosis by molecular biology (nested PCR and real-time PCR)